Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Cash & Equivalents: 2022

Historic Cash & Equivalents for Therapeutics (LENZ) over the last 1 years, with Dec 2022 value amounting to $47.7 million.

  • Therapeutics' Cash & Equivalents rose 224.50% to $183.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $183.0 million, marking a year-over-year increase of 224.50%. This contributed to the annual value of $47.7 million for FY2022, which is N/A change from last year.
  • As of FY2022, Therapeutics' Cash & Equivalents stood at $47.7 million.
  • Therapeutics' 5-year Cash & Equivalents high stood at $47.7 million for FY2022, and its period low was $47.7 million during FY2022.
  • For the 1-year period, Therapeutics' Cash & Equivalents averaged around $47.7 million, with its median value being $47.7 million (2022).